Tiny but powerful: platelets behaviour in metabolic dysfunction-associated steatotic liver disease and its evolution to liver cirrhosis

被引：0
|
作者：
Zoncape, M. [1 ,2 ,3 ,4 ]
Castelli, M. [1 ,2 ]
Sacerdoti, D. [3 ,4 ]
Minuz, P. [1 ,2 ]
Dalbeni, A. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Verona, Div Gen Med C, Dept Med, Verona, Italy
[2] Azienda Osped Univ Integrata Verona, Verona, Italy
[3] Univ Verona, Liver Unit, Verona, Italy
[4] Azienda Osped Univ Integrata Verona, Verona, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷
关键词：
D O I：
10.1016/j.dld.2024.01.100
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T-68
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [41] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [42] Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
    Noureddin, Nabil
    Copur-Dahi, Nedret
    Loomba, Rohit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 : S41 - S51
  • [43] Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
    Bernhard, Johannes
    Galli, Lukas
    Speidl, Walter S.
    Krychtiuk, Konstantin A.
    CURRENT CARDIOLOGY REPORTS, 2025, 27 (01)
  • [44] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [45] Racial disparities in incidence of cirrhosis and extrahepatic manifestations in metabolic dysfunction-associated steatotic liver disease
    Aboona, Majd
    Ghani, Leith
    Rangan, Pooja
    Chen, Vincent
    Ng, Cheng Han
    Huang, Daniel
    Muthiah, Mark
    Kim, Donghee
    Rubin, Moises Nevah
    Han, Ma Ai Thanda
    Fallon, Michael
    Wijarnpreecha, Karn
    JOURNAL OF HEPATOLOGY, 2024, 80 : S478 - S478
  • [46] RACIAL DISPARITIES IN PREVALENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Aboona, Majd B.
    Ghani, Leith K.
    Rangan, Pooja
    Chen, Vincent L.
    Ng, Cheng Han
    Huang, Daniel
    Muthiah, Mark
    Kim, Donghee
    Rubin, Moises I. Nevah
    Han, Ma Ai Thanda
    Fallon, Michael B.
    Wijarnpreecha, Karn
    GASTROENTEROLOGY, 2024, 166 (05) : S1627 - S1628
  • [47] Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis
    Amjad, Waseem
    Jiang, Zhenghui G.
    Lai, Michelle
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (08) : 1038 - 1045
  • [48] Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis A Randomized Clinical Trial
    Simon, Tracey G.
    Wilechansky, Robert M.
    Stoyanova, Stefania
    Grossman, Alessandra
    Dichtel, Laura E.
    Lauer, Georg M.
    Miller, Karen K.
    Hoshida, Yujin
    Corey, Kathleen E.
    Loomba, Rohit
    Chung, Raymond T.
    Chan, Andrew T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (11): : 920 - 929
  • [49] Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?
    Gambardella, Maria Luisa
    Abenavoli, Ludovico
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2025, 86 (02)
  • [50] Macrophage metabolism impacts metabolic dysfunction-associated steatotic liver disease and its progression
    Yang, Ming
    Liu, Shuai
    Sui, Yuxiang
    Zhang, Chunye
    IMMUNOMETABOLISM, 2024, 6 (03)
12345